title: Initiation of liver transplantation in bangladesh: report on the first two successful cases.
abstract: Liver transplantation (LT) is the treatment of choice for patients with end-stage liver disease (ESLD). Chronic liver disease due to many causes is prevalent in a significant percentage of the Bangladeshi population. Until recently, liver transplantation facilities were not available, and ESLD patients were dying without treatment. Liver transplantation is a complex procedure that requires integrated and organized approach by a multidisciplinary team. The initiation of liver transplantation in Bangladesh has faced many difficulties. These difficulties have been encountered and overcome in phases. We have successfully performed the first two living-donor liver transplantations (LDLTs) in Bangladesh. The recipient of the first LDLT was a 42-year man with cryptogenic cirrhosis, and the second one was a male of 35 years, suffering from HBV cirrhosis. Both the recipients and donors are doing well and relishing the prospect of a normal life. These two successful liver transplantations are milestones in the development of liver transplantation services in Bangladesh.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Ali
authors.forename: Subash
authors.initials: S
authors.lastname: Gupta
authors.forename: S M A
authors.initials: SM
authors.lastname: Zafar
authors.forename: Mamunur
authors.initials: M
authors.lastname: Rashid
authors.forename: Muhd Mustaque
authors.initials: MM
authors.lastname: Husain
authors.forename: Hashim
authors.initials: H
authors.lastname: Rabbi
authors.forename: A H M Tanvir
authors.initials: AH
authors.lastname: Ahmed
authors.forename: K M
authors.initials: KM
authors.lastname: Akhtar
authors.forename: Hasina
authors.initials: H
authors.lastname: Alam
mesh_terms: D000328:Adult; D001459:Bangladesh; D058625:End Stage Liver Disease / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D012720:Severity of Illness Index; D014019:Tissue Donors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents